COMPANY PROFILE

Nuritas

Explore full profile

Nature's smartest peptides, discovered by AI.

Dublin, IrelandFounded 2014Biotech & Life Sciences

Valuation $250–500M Last recorded · 2024

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Nuritas

Nature’s Most Powerful Peptides, Discovered by AI

We use artificial intelligence to unlock cell-signaling peptide ingredients for your product formulations. Discovered by AI, validated by human clinical studies, ready for your innovations.

We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin.

By translating nature’s wisdom into innovation, together, we can change the life of billions.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2014
Headquarters: Dublin, Ireland
Employees: 72
Open positions: 2
Dealroom signal: 88.5/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology, Innovative Food
Sector: Biotech & Life Sciences, Personal Health, Diabetes, Dietary Supplements
Technology: Artificial Intelligence, Big Data, Deep Tech, Machine Learning, Nanotech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

9 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Dec 2024	$42M	$168M	European Circular Bioeconomy Fund · McWin Partners · Grosvenor Food & AgTech · M&G	↗
SERIES BOther financing	Nov 2021	$43M	$173M	Clay Capital · Veronorte · Cleveland Avenue · CJ Corporation	↗

Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	EBITDA	Margin
2026		—
2025		—
2024		—
2023		—
2022		—
2021		—
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Nuritas website traffic

Latest recorded traffic for Nuritas is 17K monthly website visits, up 30.8% over the last three months. Nuritas's team grew 12.5% over the past year.

Latest monthly visits17K 3-month web change+30.8% 1-year team growth+12.5%

Monthly website visitsJun 2015–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Clinical Research AssistantDublin, County Dublin, Ireland · Other · Jul 29, 2026 Head of Clinical Trials (Maternity Cover)Dublin, County Dublin, Ireland · Other · Jul 12, 2026 Head of Clinical Trials (Maternity Leave)Dublin, County Dublin, Ireland · Other · Jun 12, 2026 Vice President, Scientific AffairsNew Canaan, CT · Data Science & Engineering · Jun 11, 2026

4 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ILiLoFAI and photonics platform for personalized drug discovery.	London, United Kingdom	Operational	40	$13M	$22M
CDC4X DiscoveryC4X Discovery - building the world's most productive drug discovery engine	Manchester, United Kingdom	Operational
LILifebitEmpowers therapeutic leaders and pioneers in precision medicine on how to access and analyse siloed biomedical data	London, United Kingdom	Operational
WGWhitelab GenomicsAI platform for accelerating genomic medicine development	Évry-Courcouronnes, France	Operational
CTCeleris TherapeuticsPredicting biomolecular interactions and designing drugs for incurable diseases	Graz, Austria	Operational
ALALLOXHarnessing the power of genetics and AI to learn the biophysical parameters governing protein function	Barcelona, Spain	Operational
ATArctic TherapeuticsTransforming drug discovery and development by harnessing the power of applied of genomics	Reykjavík, Iceland	Operational
BIBiomatterAI-powered platform designing novel, custom enzymes	Vilnius, Lithuania	Operational